A drug marketed to grow bone in osteoporosis patients also works to heal bone wounds in gum disease patients, a new study suggests.
A drug marketed to grow bone in osteoporosis patients also works to heal bone wounds in gum disease patients, a new study suggests.
New findings suggesting that bacteria in the mouth and/or intestine can affect the the outcome pathogenesis of atherosclerosis and lead to new treatment strategies, reveals research from Sweden.